Duong CP - Search Results

1

Anti-PD-1 antibody therapy potently enhances the eradication of established tumors by gene-modified T cells.

John LB, Devaud C, Duong CP, Yong CS, Beavis PA, Haynes NM, Chow MT, Smyth MJ, Kershaw MH, Darcy PK. John LB, et al. Among authors: duong cp. Clin Cancer Res. 2013 Oct 15;19(20):5636-46. doi: 10.1158/1078-0432.CCR-13-0458. Epub 2013 Jul 19. Clin Cancer Res. 2013. PMID: 23873688

2

Oncolytic virus and anti-4-1BB combination therapy elicits strong antitumor immunity against established cancer.

John LB, Howland LJ, Flynn JK, West AC, Devaud C, Duong CP, Stewart TJ, Westwood JA, Guo ZS, Bartlett DL, Smyth MJ, Kershaw MH, Darcy PK. John LB, et al. Among authors: duong cp. Cancer Res. 2012 Apr 1;72(7):1651-60. doi: 10.1158/0008-5472.CAN-11-2788. Epub 2012 Feb 7. Cancer Res. 2012. PMID: 22315352

3

Tumor ablation by gene-modified T cells in the absence of autoimmunity.

Wang LX, Westwood JA, Moeller M, Duong CP, Wei WZ, Malaterre J, Trapani JA, Neeson P, Smyth MJ, Kershaw MH, Darcy PK. Wang LX, et al. Among authors: duong cp. Cancer Res. 2010 Dec 1;70(23):9591-8. doi: 10.1158/0008-5472.CAN-10-2884. Epub 2010 Nov 23. Cancer Res. 2010. PMID: 21098715

4

Enhancing the specificity of T-cell cultures for adoptive immunotherapy of cancer.

Duong CP, Westwood JA, Berry LJ, Darcy PK, Kershaw MH. Duong CP, et al. Immunotherapy. 2011 Jan;3(1):33-48. doi: 10.2217/imt.10.81. Immunotherapy. 2011. PMID: 21174556

5

Chimeric antigen receptor-redirected T cells display multifunctional capacity and enhanced tumor-specific cytokine secretion upon secondary ligation of chimeric receptor.

Henderson MA, Yong CS, Duong CP, Davenport AJ, John LB, Devaud C, Neeson P, Westwood JA, Darcy PK, Kershaw MH. Henderson MA, et al. Among authors: duong cp. Immunotherapy. 2013 Jun;5(6):577-90. doi: 10.2217/imt.13.37. Immunotherapy. 2013. PMID: 23725282

6

Tissues in different anatomical sites can sculpt and vary the tumor microenvironment to affect responses to therapy.

Devaud C, Westwood JA, John LB, Flynn JK, Paquet-Fifield S, Duong CP, Yong CS, Pegram HJ, Stacker SA, Achen MG, Stewart TJ, Snyder LA, Teng MW, Smyth MJ, Darcy PK, Kershaw MH. Devaud C, et al. Among authors: duong cp. Mol Ther. 2014 Jan;22(1):18-27. doi: 10.1038/mt.2013.219. Epub 2013 Sep 19. Mol Ther. 2014. PMID: 24048441 Free PMC article.

7

Combination anti-CD137 and anti-CD40 antibody therapy in murine myc-driven hematological cancers.

Westwood JA, Matthews GM, Shortt J, Faulkner D, Pegram HJ, Duong CP, Chesi M, Bergsagel PL, Sharp LL, Huhn RD, Darcy PK, Johnstone RW, Kershaw MH. Westwood JA, et al. Among authors: duong cp. Leuk Res. 2014 Aug;38(8):948-54. doi: 10.1016/j.leukres.2014.05.010. Epub 2014 Jun 2. Leuk Res. 2014. PMID: 24934848

8

Cancer immunotherapy utilizing gene-modified T cells: From the bench to the clinic.

Duong CP, Yong CS, Kershaw MH, Slaney CY, Darcy PK. Duong CP, et al. Mol Immunol. 2015 Oct;67(2 Pt A):46-57. doi: 10.1016/j.molimm.2014.12.009. Epub 2015 Jan 13. Mol Immunol. 2015. PMID: 25595028 Review.

9

Enhancing adoptive immunotherapy of cancer.

Westwood JA, Berry LJ, Wang LX, Duong CP, Pegram HJ, Darcy PK, Kershaw MH. Westwood JA, et al. Among authors: duong cp. Expert Opin Biol Ther. 2010 Apr;10(4):531-45. doi: 10.1517/14712591003610622. Expert Opin Biol Ther. 2010. PMID: 20132063 Review.

10

Autoimmunity associated with immunotherapy of cancer.

Amos SM, Duong CP, Westwood JA, Ritchie DS, Junghans RP, Darcy PK, Kershaw MH. Amos SM, et al. Among authors: duong cp. Blood. 2011 Jul 21;118(3):499-509. doi: 10.1182/blood-2011-01-325266. Epub 2011 Apr 29. Blood. 2011. PMID: 21531979 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

64 results

Search Page